Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Maintenance With Azacitidine in MDS Patients Achieving Complete or Partial Remission (CR or PR) After Intensive Chemotherapy

NCT00446303 is registered in ClinicalTrials.gov with Groupe Francophone des Myelodysplasies as lead sponsor.

NCT NCT00446303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00446303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Maintenance With Azacitidine in MDS Patients Achieving Complete or Partial Remission (CR or PR) After Intensive Chemotherapy
Lead sponsor
Groupe Francophone des Myelodysplasies
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2006
Completion date
July 31, 2010
Enrollment
39 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, myelocytic, acute, myelodysplastic syndromes